Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhance...( MOUNTAIN VIEW Calif. Dec. 1 /- This w...)

MOUNTAIN VIEW, Calif., Dec. 1 /PRNewswire/ -- This week Frost & Sullivan announced that Martek Biosciences Corporation, creator of the fast-growing life'sDHA(TM) brand of DHA (docosahexaenoic acid), is the 2008 recipient of the North American Frost & Sullivan Customer Value Enhancement Award. This award is in recognition of Martek's long-standing, successful customer relationships and innovative marketing and branding initiatives that have helped to establish the company as a leading global provider of DHA omega-3 products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )

Martek's solid research pipeline along with strategic alliances and a strong intellectual property strategy has further cemented its superiority in the market. Martek has developed a strong intellectual property position globally by strategically developing multiple layers of patent protection. Martek's patent portfolio includes more than 700 granted patents and pending applications worldwide. Its strong patent portfolio has ensured that it is the only source of DHA and ARA used in infant formula sold in the United States.

"The company has successfully established significant and long-term supply agreements and has capitalized on its strength of being a leading supplier of vegetarian DHA and arachidonic acid (ARA)," notes Frost & Sullivan Research Analyst Arthi V. "Martek has signed multi-year sole supplier agreements with a number of leading infant formula manufacturers to further strengthen its relationships with key customers."

Martek has also focused on comprehensive marketing initiatives, making extensive use of various media and consumer outreach strategies to promote its brand, life'sDHA. This has led to double digit growth in consumer awareness of the life'sDHA brand since the br
'/>"/>